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EPIGENETIC LANDSCAPE IN PPARg2 IN THE ENHANCEMENT OF ADIPOGENESIS
OF MOUSE OSTEOPOROTIC BONE MARROW STROMAL CELL
Qiming Fan
Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of
Medicine, China
Introduction: Osteoporosis is one of the most prevalent skeletal system diseases;
yet, its pathophysiological mechanisms remain elusive. Adipocytes accumulate
remarkably in bone marrow of osteoporotic patients. The potential processes
and molecular mechanisms underlying adipogenesis in osteoporotic BMSCs have
attracted significant attention as adipocytes and osteoblasts share common pre-
cursor cells. Some environmental factors influence bone mass through epigenetic
mechanisms; however, the role of epigenetic modifications in osteoporosis is
just beginning to be investigated, and there is still little data regarding their
involvement. In the current study, we investigated how epigenetic modifications,
including DNA methylation and histone modifications, lead to adipogenesis in bone
marrow during osteoporosis.
Subjects and Methods: A glucocorticoid-induced osteoporosis (GIO) mouse model
was established, and BMSCs were isolated from bone marrow. Osteoporotic BMSC
osteogenic and adipogenic potentials were evaluated through ALP staining, Aliz-
arin red staining, oil red O staining and quantitative RT-PCR. In osteoporotic
BMSC, PPARg2 regulatory region DNA methylation status was studied through bisul-
fite sequencing PCR and the status of histone acetylation and H3K9 di-methylation
in PPARg2 regulatory region was studied through Chromatin immunoprecipitation
(ChIP). Western blot, lentivirus, luciferase reporter assay and in vitro methylation
assay were employed to inhibit adipogenic potential of osteoporotic BMSC through
altering epigenetic modification status in PPARg2 regulatory region.
Results: Compared with normal BMSCs, osteoporotic BMSCs had significantly
increased adipogenesis potential and decreased osteogenesis potential. In osteo-
porotic BMSCs, PPARg2 regulatory region DNA hypo-methylation, histone 3 and 4
hyper-acetylation and H3K9 hypo-di-methylation were observed. These epigenetic
modifications were involved not only in PPARg2 expression but also in osteoporotic
BMSC adipogenic differentiation potential. We also found that Wnt/b-catenin
signal played an important role in the establishment and maintenance of epige-
netic modifications at PPARg2 promoter in osteoporotic BMSCs. Finally, we
inhibited adipogenesis and rescued osteogenesis of osteoporotic BMSCs by modu-
lating those epigenetic modifications.
Discussion and Conclusion: In the current study, a significant enhancement of adi-
pogenic differentiation potential was observed for osteoporotic BMSCs compared
with normal BMSCs, and these results are consistent with a number of previous re-
ports. The current study aimed to elucidate the molecular mechanisms underlying
osteoporotic BMSC adipogenesis. The environment significantly affects bone mass,
even during gestation: the intra-uterine environment was shown to play an essen-
tial role in fetal skeleton development not only at birth but also later in life. The
current study provides direct evidence that the epigenetic landscape of the
PPARg2 regulatory region is altered in osteoporotic BMSCs, with changes including
DNA hypo-methylation, histone hyper-acetylation and H3K9 hypo-di-methylation,
as well as evidence regarding how these epigenetic modifications regulate PPARg2
expression and osteoporotic BMSC adipogenic differentiation. In summary, the re-
sults of the current study suggest that DNA is de-methylated, H3 and H4 tails are
acetylated, and H3K9 di-methylation is reduced in PPARg2 regulatory regions in
osteoporotic BMSCs compared with normal BMSCs. These epigenetic modifications
lead to an active chromatin structure that activates PPARg2 transcription in
response to adipogenic induction. Consistent with this idea, osteoporotic BMSCs
showed enhanced potential for adipogenic differentiation in response to PPARg2
epigenetic modifications.
http://dx.doi.org/10.1016/j.jot.2016.06.154Session: Disease & Treatment d Ligament, Tendon and Meniscus
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A NEW ANIMAL MODEL OF TENDINOPATHYdFAILED TENDON HEALING BY
HYDROGEN PEROXIDE
Sai Chuen Fu a, Man Yi Yeung a, Christer G. Rolf b, Kai Ming Chan a, Leung
Kim Hung a
aThe Chinese University of Hong Kong, Hong Kong, China
bKarolinska Institutet, Sweden
Introduction: Tendinopathy includes cases with chronic tendon pain as well as
cases with spontaneous tendon ruptures. There is no consensus on representative
animal model of tendinopathy, which affects development of new treatment stra-
tegies. Animal models by overuse training could induce tendon degeneration, but
painful response and mechanical weakness were not recorded. Collagenase injec-
tion is another common method to induce tendinopathic changes with painfulresponses, but this aetiopathological factors may not be applicable to humans.
As overuse can impose both mechanical stress and oxidative stress to tendons,
we propose to develop a new tendinopathy animal model by imposing oxidative
stress to result in failed tendon healing found in tendinopathy.
Subjects and Methods: A total of 24 male Sprague Dawley rats (8e10 weeks old,
200e300 g) were used in the study. A patellar tendon window injury was created
on the right knee according to our previous protocol. Postoperatively the rats
were randomly assigned to three groups (nZ 8), which received three weekly sub-
cutaneous injections over the patellar tendon (from the 3rd to 5th week post oper-
ation) of either saline, 50 mM or 500 mM H2O2 solution (100 ml per injection). Animal
gait data (CatWalk XT, Noldus) for pain assessment and 3D ultrasound imaging data
(Vevo770, Visualsonics) for tendinopathic changes were collected non-invasively at
pre-injury and 6-week post operation (nZ 8). At day 42, the rats were euthanized
to harvest knee specimens for either histology (n Z 2) or tensile mechanical test
(n Z 6). Repeated measures ANOVA and the non-parametric Kruskal Wallis test
were used to compare the treatment effects. Statistical significance was accepted
at a Z 0.05.
Results: The mechanical properties (ultimate stress, elastic modulus) of the heal-
ing patellar tendons were significantly impaired by 50 mM H2O2 treatment
(pZ 0.021). Treatments with 50 mM H2O2 also led to pain-associated gait asymme-
try (pZ 0.038) and significant tendon swelling at distal patella region as compared
to the saline control. Histological examination showed hypercellularity and matrix
disturbance in the 50 mM H2O2 treatment group.
Discussion and Conclusion: The results demonstrated that H2O2 impaired tendon
healing and elicited tendinopathic changes with respect to pain, structural abnor-
malities and mechanical weakening. Failed tendon healing in this animal model
resembled most tendinopathic features in humans, and the pathological changes
were attributed to oxidative stress which is presumably involved in overuse. This
animal model is thus useful for investigation of pathogenesis of tendinopathy as
well as development of new treatment strategies.
http://dx.doi.org/10.1016/j.jot.2016.06.155Session: Traumatology e Fracture Healing
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ESTROGEN RECEPTOR EXPRESSION IN OSTEOBLASTS IS NOT ENHANCED IN
VITRO BY LOW-MAGNITUDE HIGH-FREQUENCY VIBRATIONAL STIMULATION IN
THE ABSENCE OF ESTROGEN
Simon K. H. Chow a,b, Kwok-Sui Leung a,c, Wing-Hoi Cheung a,b,c
aMusculoskeletal Research Laboratory, Department of Orthopaedics and
Traumatology, The Chinese University of Hong Kong, Hong Kong
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Background: Low-magnitude high-frequency vibration (LMHFV) enhances ovariec-
tomy-induced osteoporotic fracture healings in rats [1,2] in terms of increased
callus formation as shown in callus morphometry, gene expression, and angiogen-
esis [1e3]. Mechanical stimulation can be transmitted by estrogen receptors (ER),
and that LMHFV was shown to enhance ER expression and callus formation capacity
at early to mid-stage of the healing process in vivo [4]. We hypothesized that the
LMHFV may enhance ER expression in osteoblasts that contributes to enhanced
osteogenic activities.
Methods: Primary cultures of 24 SD rats (nZ4 per group) calvaria osteoblasts were
treated with or without LMHFV stimulation. Different groups (CTRL+E2, VT+E2,
CTRL, VT, and VT+ICI) were substituted with or without estrogen at 1.0108 M
to mimic estrogen (E2) and estrogen deficiency (CTRL) in osteoblasts; and with
or without the ER antagonist ICI 182, 780 at 1.0108 M to investigate the role
of ER in osteogenic effect in response to LMHFV at 20 min/day, 5days/week,
35Hz and 0.3g. ER expression was assessed 4 hours after mechanical stimulation.
Osteoblast differentiation (ALP activity) and osteogenic activity (calcium nodule
formation) were assessed at week 2 after LMHFV treatments.
Results: ER-a expression was up-regulated in the VT+E2 group compared to the
CTRL+E2 group without difference (pZ0.229), but higher than the CTRL and
VT+ICI groups (pZ0.045, pZ0.020, respectively). No difference was detected
among the CTRL, VT and VT+ICI groups. ALP activity was found to be increased
in the VT+E2 group compared to the CTRL+E2 group, however without difference
(pZ0.067); and increased in the VT group compared to the CTRL group with sig-
nificance (pZ0.012). The ALP activity was detected to be lowered in the VT+ICI
group compared to the VT group with significance (pZ0.016). No difference was
detected between the VT+E2 and CTRL+E2 groups (pZ0.800); and between the
VT and CTRL groups (pZ0.956). Difference was detected between the CTRL+E2
and CTRL groups (pZ0.018). No difference was detected between the VT+ICI
and the CTRL groups (pZ1.000) and between the VT+ICI and VT groups
(pZ0.456).
